There are currently nine reviews and protocols in The Cochrane Library (http://www.thecochranelibrary.com/view/0/index.html) which addresses the effects of anti-VEGF on specific eye diseases, including one about the systemic safety of ranibizumab and bevacizumab. This evidence concerns the gene VEGFA and eye disorder.